Understand first
We begin with the actual process, system, risk and business context before defining the solution.
SELECTED ENGAGEMENT EXPERIENCE
Real-world challenges.
Real-world challenges.
Structured solutions. Sustainable outcomes.
For nine years, ValiStera has supported regulated organizations across validation, GMP compliance, sterile manufacturing, regulatory CMC and digital quality. Our work is built around technical depth, confidentiality, practical execution and a client-first consulting model.
Discuss an engagement
9
Years serving clients
Long-term technical support across regulated pharmaceutical quality and compliance challenges.
99.3%
Client retention
Built on responsiveness, technical clarity, confidentiality and sustained client value.
CLIENT-FIRST CONSULTING
Experience built around trust, continuity and technical accountability.
ValiStera approaches every engagement by first understanding the operating environment, regulatory risk and business objective. The goal is not simply to produce documentation, but to create solutions that can be implemented, defended and maintained throughout the lifecycle.
Protect confidentiality
Client identities, product information, proprietary processes and sensitive technical data remain protected.
Build for use
Recommendations are structured for practical implementation, not theoretical compliance alone.
Stay accountable
Engagements are managed around clear scope, evidence, technical reasoning and sustainable outcomes.
CONFIDENTIALITY BY DESIGN
Client work stays confidential.
The engagement examples below are intentionally anonymised and presented at a representative engagement level. Client names, products, facilities, proprietary processes and confidential technical information are not disclosed.
REPRESENTATIVE ENGAGEMENTS
Selected experience across critical pharmaceutical quality challenges.
01
QUALIFICATION & VALIDATION
Sterile facility qualification and lifecycle readiness
Challenge
Qualification activities across equipment, utilities and cleanroom systems required stronger lifecycle structure, traceability and alignment between technical evidence and GMP expectations.
ValiStera approach
Established a risk-based qualification framework connecting intended use, criticality, document hierarchy, protocol strategy, traceability and remediation control.
Typical deliverables
- Qualification strategy and gap assessment
- DQ / IQ / OQ / PQ documentation support
- Requirements and traceability review
- Deviation and remediation tracking
- Validated-state lifecycle recommendations
Outcome focus
Clearer qualification evidence, stronger lifecycle control and improved inspection readiness.
02
GMP & INSPECTION READINESS
Quality-system remediation and inspection preparation
Challenge
Recurring observations, inconsistent investigation quality and fragmented evidence retrieval created avoidable compliance risk ahead of inspection activity.
ValiStera approach
Structured the remediation programme around risk prioritisation, CAPA governance, documentation quality, evidence retrieval and subject-matter-expert readiness.
Typical deliverables
- GMP gap and risk register
- CAPA and remediation roadmap
- Inspection evidence architecture
- SME preparation and response support
- Effectiveness-verification framework
Outcome focus
More defensible evidence, faster retrieval and a stronger state of inspection readiness.
03
REGULATORY CMC & STERILE PRODUCTS
Lifecycle change assessment and submission readiness
Challenge
Complex sterile-product changes required coordinated regulatory assessment, technically consistent CMC documentation and alignment between source evidence, change control and submission strategy.
ValiStera approach
Connected manufacturing and quality evidence with regulatory impact assessment, CMC content review, lifecycle considerations and authority-response readiness.
Typical deliverables
- Regulatory impact and change assessment
- CMC source-document review
- Submission-readiness review
- Deficiency and authority-response support
- Lifecycle documentation coordination
Outcome focus
Stronger submission consistency, clearer technical justification and improved lifecycle coordination.
04
DIGITAL QUALITY & CSV
Risk-based computerized-system assurance and remediation
Challenge
Validation evidence, requirements traceability and data-integrity controls needed a more proportionate and lifecycle-oriented approach across GxP computerized systems.
ValiStera approach
Applied intended-use and risk-based assurance principles across system impact, requirements, supplier evidence, testing, access control, audit trails and periodic review.
Typical deliverables
- System inventory and GxP impact assessment
- Validation plans and risk assessments
- URS and traceability review
- Test-evidence and supplier-evidence review
- Access, audit-trail and periodic-review support
Outcome focus
More proportionate assurance, stronger traceability and a maintainable validated digital state.
Related servicesDigital Quality & CSV
LONG-TERM CLIENT RELATIONSHIPS
99.3% retention reflects how we work.
Client retention is built through responsiveness, technical ownership, transparent communication, confidentiality and solutions that remain useful after the immediate project is complete.
Client-first engagement
Clear technical reasoning
Confidentiality
Lifecycle thinking
Practical implementation
Long-term support
DISCUSS YOUR CHALLENGE
Discuss an engagement
Need support with a complex quality, validation or regulatory challenge?
Tell us where the risk is. We will help structure the path forward.
COMPLIANCE-MINDED. EVIDENCE-LED.
Remote services available worldwide
Work is scoped against applicable client procedures, regulatory requirements and guidance. Depending on the engagement, reference frameworks may include GxP, FDA 21 CFR requirements, EU GMP Annexes 1, 11 & 15, ICH Q9(R1), and ISO 9001:2015 quality-management principles.